Scarica l'app Stockscreener
196.63
1.29%
-2.57
Pre-mercato:
198.16
1.53
+0.78%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché BDX Giù?
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$199.20
Aprire:
$198.46
Volume 24 ore:
1.29M
Relative Volume:
0.47
Capitalizzazione di mercato:
$56.36B
Reddito:
$21.39B
Utile/perdita netta:
$1.61B
Rapporto P/E:
35.37
EPS:
5.56
Flusso di cassa netto:
$2.55B
1 W Prestazione:
+0.84%
1M Prestazione:
+12.15%
6M Prestazione:
-13.54%
1 anno Prestazione:
-16.27%
Intervallo 1D:
$196.37
$198.85
Intervallo di 1 settimana:
$194.27
$200.22
Portata 52W:
$163.33
$251.99
Becton Dickinson Co Stock (BDX) Company Profile
Nome
Becton Dickinson Co
Settore
Industria
Telefono
(201) 847-6800
Indirizzo
ONE BECTON DR, FRANKLIN LAKES
Confronta BDX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
BDX
Becton Dickinson Co
|
196.63 | 55.89B | 21.39B | 1.61B | 2.55B | 5.56 |
|
ISRG
Intuitive Surgical Inc
|
469.88 | 172.53B | 9.15B | 2.63B | 1.99B | 7.17 |
|
ALC
Alcon Inc
|
79.18 | 43.59B | 9.93B | 1.12B | 1.43B | 2.26 |
|
RMD
Resmed Inc
|
288.34 | 41.89B | 5.15B | 1.40B | 1.65B | 9.51 |
|
WST
West Pharmaceutical Services Inc
|
242.63 | 17.48B | 2.96B | 487.70M | 344.00M | 6.68 |
Becton Dickinson Co Stock (BDX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-05-22 | Downgrade | Citigroup | Buy → Neutral |
| 2025-05-02 | Downgrade | Goldman | Buy → Neutral |
| 2025-05-02 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2025-05-02 | Downgrade | Raymond James | Outperform → Mkt Perform |
| 2025-05-01 | Downgrade | BofA Securities | Buy → Neutral |
| 2025-05-01 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2025-05-01 | Downgrade | William Blair | Outperform → Mkt Perform |
| 2024-10-01 | Aggiornamento | Citigroup | Neutral → Buy |
| 2024-05-30 | Iniziato | Goldman | Buy |
| 2023-07-24 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
| 2023-05-30 | Ripresa | Morgan Stanley | Overweight |
| 2023-05-05 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2023-04-12 | Aggiornamento | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2023-01-03 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2022-12-12 | Aggiornamento | Citigroup | Sell → Neutral |
| 2022-07-11 | Downgrade | Citigroup | Neutral → Sell |
| 2022-06-24 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2022-03-18 | Ripresa | Raymond James | Mkt Perform |
| 2022-03-02 | Ripresa | BofA Securities | Neutral |
| 2021-12-08 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2021-08-06 | Downgrade | JP Morgan | Overweight → Neutral |
| 2021-05-25 | Iniziato | Barclays | Equal Weight |
| 2020-12-15 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2020-12-15 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2020-07-09 | Aggiornamento | Barclays | Equal Weight → Overweight |
| 2020-06-01 | Ripresa | Goldman | Buy |
| 2020-03-05 | Iniziato | Citigroup | Neutral |
| 2020-02-07 | Downgrade | Cowen | Outperform → Market Perform |
| 2020-02-07 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2020-02-07 | Downgrade | Raymond James | Strong Buy → Outperform |
| 2020-02-06 | Downgrade | Cowen | Outperform → Market Perform |
| 2020-01-08 | Downgrade | Barclays | Overweight → Equal Weight |
| 2019-05-13 | Aggiornamento | Barclays | Equal Weight → Overweight |
| 2018-12-07 | Iniziato | Deutsche Bank | Buy |
| 2018-10-16 | Iniziato | Barclays | Equal Weight |
| 2018-06-21 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2018-04-10 | Aggiornamento | Citigroup | Neutral → Buy |
| 2018-01-19 | Ripresa | BofA/Merrill | Buy |
| 2018-01-05 | Aggiornamento | Citigroup | Sell → Neutral |
| 2018-01-05 | Iniziato | KeyBanc Capital Mkts | Overweight |
| 2018-01-03 | Iniziato | Evercore ISI | Outperform |
| 2017-12-29 | Reiterato | Deutsche Bank | Buy |
Mostra tutto
Becton Dickinson Co Borsa (BDX) Ultime notizie
Becton Dickinson and Company stock chart pattern explainedJuly 2025 Pullbacks & Daily Volume Surge Trade Alerts - Newser
Why Becton Dickinson Shares Are Under Scrutiny - TipRanks
Becton, Dickinson and Company (NYSE:BDX) Stock Unloaded Rep. Lisa C. McClain - Defense World
BD PosiFlush™ SafeScrub Study: A Potential Game-Changer for Medical Device Safety - TipRanks
Intravenous Catheters Market Size to Hit USD 16.47 Billion by 2032, at 6.9% CAGR | Report by SNS Insider - GlobeNewswire Inc.
Becton Dickinson and Company stock trend outlook and recovery pathTrade Volume Report & Real-Time Stock Price Movement Reports - Newser
Is Becton Dickinson and Company stock reversal real or fakeRate Cut & Fast Entry High Yield Tips - Newser
Becton, Dickinson and Company Stock: Is Wall Street Bullish or Bearish? - inkl
Becton, Dickinson: Great Time To Buy This Dividend Aristocrat (BDX) - Seeking Alpha
Intraday pattern recognizer results for Becton Dickinson and CompanyWeekly Trend Report & AI Powered Market Entry Ideas - Newser
Does The Market Have A Low Tolerance For Becton, Dickinson and Company's (NYSE:BDX) Mixed Fundamentals? - 富途牛牛
Is Now a Good Time to Reenter Becton Dickinson and Company2025 Breakouts & Breakdowns & Low Drawdown Momentum Trade Ideas - newsimpact.co.kr
Becton Dickinson's (NYSE:BDX) Solid Earnings Have Been Accounted For Conservatively - 富途牛牛
Brandes Investment Partners, LP Makes Significant Addition to Becton Dickinson & Co - Yahoo Finance
Morgan Stanley Forecasts Strong Price Appreciation for Becton, Dickinson and Company (NYSE:BDX) Stock - Defense World
Becton, Dickinson and Company Submits Application to the FDA for a New, At-Home HPV Test - MSN
Becton, Dickinson and Company (NYSE:BDX) Stock Price Expected to Rise, Morgan Stanley Analyst Says - Defense World
Diamond Hill Capital's Strategic Moves: Significant Reduction in Becton Dickinson & Co - Yahoo Finance
Morgan Stanley Reaffirms Their Buy Rating on Becton Dickinson (BDX) - The Globe and Mail
Director’s Bold Move: A Million-Dollar Bet on Becton Dickinson! - TipRanks
Judge OKs Becton Dickinson's $9M Investor Settlement - Law360
Becton Dickinson price target raised to $197 from $196 at Morgan Stanley - TipRanks
Morgan Stanley Maintains Becton Dickinson & Co(BDX.US) With Buy Rating, Raises Target Price to $197 - 富途牛牛
Becton, Dickinson rises as strong Q3 results lead to guidance raise - MSN
4 Overlooked Dividend Aristocrat Stocks with Up To 60%+ Growth Potential - 24/7 Wall St.
BD Careers | Jobs at BD | We are the Makers of Possible - Becton Dickinson
Earnings Beat: Becton, Dickinson and Company Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models - 富途牛牛
Piper Sandler Maintains Becton Dickinson & Co(BDX.US) With Hold Rating, Raises Target Price to $200 - 富途牛牛
Becton, Dickinson and Company (NYSE:BDX) Raised to Buy at Wall Street Zen - Defense World
J.P. Morgan Maintains Becton Dickinson & Co(BDX.US) With Hold Rating, Raises Target Price to $190 - 富途牛牛
Director Makes Significant Move with Becton Dickinson Stock! - TipRanks
A Quick Look at Today's Ratings for Becton Dickinson & Co(BDX.US), With a Forecast Between $183 to $200 - 富途牛牛
Becton Dickinson: Wells Fargo maintains Equal-Weight, raises PT to $184 from $172. - AInvest
Becton, Dickinson and Company (NYSE:BDX) Q3 2025 Earnings Call Transcript - Insider Monkey
Becton Dickinson price target raised to $200 from $185 at Piper Sandler - TipRanks
Piper Sandler raises Becton Dickinson stock price target to $200 on earnings beat - Investing.com
William Blair Maintains Becton Dickinson & Co(BDX.US) With Hold Rating - 富途牛牛
BD revenue up 10.4% to USD 5.5 billion in Q3 2025 - Medical Buyer
Becton Dickinson & Co (BDX) Q3 2025 Earnings Call Highlights: Strong Revenue Growth and ... By GuruFocus - Investing.com Canada
Becton Dickinson Reports Strong Q3 2025 Results - TipRanks
Becton Dickinson & Co. stock outperforms competitors on strong trading day - MSN
Becton, Dickinson and Co’s Optimistic Earnings Call - TipRanks
Becton Dickinson: Fiscal Q3 Earnings Snapshot - Chron
Becton Dickinson and Co reports results for the quarter ended June 30Earnings Summary - TradingView
Becton Dickinson Q3 Beats Estimates On Medical Device Boom - inkl
Earnings call transcript: Becton Dickinson Q3 2025 earnings beat forecasts, stock surges - Investing.com
Becton Dickinson Earnings: Return to Organic Growth; Raised EPS Guidance; Shares Remain Undervalued - Morningstar
Becton, Dickinson stock rises on Q3 beat (BDX:NYSE) - Seeking Alpha
Becton, Dickinson and Company 2025 Q3ResultsEarnings Call Presentation (NYSE:BDX) - Seeking Alpha
Becton, Dickinson Boosts FY25 Adj. EPS OutlookUpdate - Nasdaq
Becton Dickinson Q3 FY25 presentation: Organic growth accelerates, guidance raised - Investing.com India
Becton Dickinson Co Azioni (BDX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Becton Dickinson Co Azioni (BDX) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Fraser Claire | Director |
Aug 08 '25 |
Sale |
192.30 |
863 |
165,955 |
23,143 |
2.30%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):